This content is machine translated Behçet's disease Apremilast approved for the treatment of oral aphthae Behçet’s disease is a rare, chronic, multisystemic inflammatory disease that causes vasculitis. Oral aphthae occur in more than 97% of affected individuals and are associated with significant impairment of quality…
View Post 3 min This content is machine translated Apremilast “Real-world evidence” in plaque psoriasis with limited skin involvement. The results of the international multicenter study APPRECIATE show a significant symptom reduction including skin involvement of specific sites. In addition, a significant improvement in quality of life was measurable.
